Drug Trial Radar · NCT03345342
A Study of Paliperidone Palmitate 6-Month Formulation
Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
841
Actual
Start
Nov 20, 2017
Primary completion
May 8, 2020
Study completion May 8, 2020
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Nov 17, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate that injection cycles consisting of a single administration of paliperidone palmitate 6-month (PP6M) are not less effective than 2 sequentially administered injections of paliperidone palmitate 3-month PP3M) (350 or 525 mg eq.) for the prevention of relapse in participants with schizophrenia previously stabilized on corresponding doses of paliperidone palmitate 1-month (PP1M) (100 or 150 mg eq.) or PP3M (350 or 525 mg eq.).
Conditions
- Schizophrenia
Interventions
PP6MDrug
Participants will receive intramuscular injection of PP6M.
PP3M 350 mg eq.Drug
Participants will receive intramuscular injection of PP3M 350 mg eq.
PP3M 525 mg eq.Drug
Participants will receive intramuscular injection of PP3M 525 mg eq.
PP1MDrug
Participants will receive intramuscular injection of PP1M 50 to 150 mg eq.
PlaceboOther
Participants will receive matching placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Relapse During the Double-Blind (DB) PhaseTime frame: Up to 12 months of DB Phase
Locations
138 sites in 21 countries. Site status is shown where the registry gives one.
Woodland Research Northwest
Rogers, Arkansas
California Pharmaceutical Research Institute, Inc.
Anaheim, California
ATP Clinical Research
Costa Mesa, California
Collaborative NeuroScience Network
Garden Grove, California
Synergy East
Lemon Grove, California
Pacific Research Partners
Oakland, California
SF-Care, Inc
San Rafael, California
New Life Medical Research Center, Inc.
Hialeah, Florida
Clintex Research Group
Miami, Florida
Florida Research Center Inc.
Miami, Florida
Olympian Clinical Research
Tampa, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
Uptown Research Institute
Chicago, Illinois
Alexian Behavioral Health Hospital
Hoffman Estates, Illinois
Ascension via Christi Research
Wichita, Kansas
Massachusetts General Hospital
Boston, Massachusetts
Cherry Street Services, Inc.
Grand Rapids, Michigan
St. Louis Clinical Trials
St Louis, Missouri
The Zucker Hillside Hospital
Glen Oaks, New York
Clinical Trials of America Inc
Hickory, North Carolina
Wexner Medical Center at the Ohio State University
Columbus, Ohio
Midwest Clinical Research Center
Dayton, Ohio
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania
Future Search Trials of Dallas
Dallas, Texas
Psychiatric and Behavioral Solutions
Salt Lake City, Utah
Fundacion para el Estudio y Tratamiento de las Enfermedades Mentales
Buenos Aires, Argentina
CEN
Córdoba, Argentina
Sanatorio Prof. Leon S. Morra
Córdoba, Argentina
Instituto de Neurociencias San Agustin
La Plata, Argentina
Clinica Privada de Salud Mental Santa Teresa de Ávila
La Plata, Argentina
C I A P Centro de investigacion y Asistencia en Psiquiatria
Rosario, Argentina
The Lyell McEwin Hospital
Elizabeth Vale, Australia
Neuro Trials Victoria
Noble Park, Australia
Trial Tech Tecnologia em Pesquisas com Medicamentos
Curitiba, Brazil
Instituto Bairral de Psiquiatria
Itapira, Brazil
Hospital das Clinicas de Porto Alegre
Porto Alegre, Brazil
Ruschel Medicina e Pesquisa Clínica Ltda
Rio de Janeiro, Brazil
CPQuali Pesquisa Clinica LTDA ME
São Paulo, Brazil
SPDM - Associacao Paulista para o Desenvolvimento da Medicina - Hospital Sao Paulo
São Paulo, Brazil
Hospital Das Clinicas Da Faculdade De Medicina Da USP
São Paulo, Brazil
Showing 40 of 138 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.